» Articles » PMID: 35834477

Poxviruses Package Viral Redox Proteins in Lateral Bodies and Modulate the Host Oxidative Response

Overview
Journal PLoS Pathog
Specialty Microbiology
Date 2022 Jul 14
PMID 35834477
Authors
Affiliations
Soon will be listed here.
Abstract

All poxviruses contain a set of proteinaceous structures termed lateral bodies (LB) that deliver viral effector proteins into the host cytosol during virus entry. To date, the spatial proteotype of LBs remains unknown. Using the prototypic poxvirus, vaccinia virus (VACV), we employed a quantitative comparative mass spectrometry strategy to determine the poxvirus LB proteome. We identified a large population of candidate cellular proteins, the majority being mitochondrial, and 15 candidate viral LB proteins. Strikingly, one-third of these are VACV redox proteins whose LB residency could be confirmed using super-resolution microscopy. We show that VACV infection exerts an anti-oxidative effect on host cells and that artificial induction of oxidative stress impacts early and late gene expression as well as virion production. Using targeted repression and/or deletion viruses we found that deletion of individual LB-redox proteins was insufficient for host redox modulation suggesting there may be functional redundancy. In addition to defining the spatial proteotype of VACV LBs, these findings implicate poxvirus redox proteins as potential modulators of host oxidative anti-viral responses and provide a solid starting point for future investigations into the role of LB resident proteins in host immunomodulation.

Citing Articles

Single-cell analysis of VACV infection reveals pathogen-driven timing of early and late phases and host-limited dynamics of virus production.

Howell L, Gracie N, Newsome T PLoS Pathog. 2024; 20(8):e1012423.

PMID: 39093901 PMC: 11347022. DOI: 10.1371/journal.ppat.1012423.


Natural Immunomodulatory Agents as a Complementary Therapy for Poxviruses.

Ali S, Salama A Adv Exp Med Biol. 2024; 1451:337-354.

PMID: 38801589 DOI: 10.1007/978-3-031-57165-7_22.


Poxvirus A51R proteins regulate microtubule stability and antagonize a cell-intrinsic antiviral response.

Seo D, Brito Oliveira S, Rex E, Ye X, Rice L, Guimaraes da Fonseca F Cell Rep. 2024; 43(3):113882.

PMID: 38457341 PMC: 11023057. DOI: 10.1016/j.celrep.2024.113882.


Multi-modal cryo-EM reveals trimers of protein A10 to form the palisade layer in poxvirus cores.

Datler J, Hansen J, Thader A, Schlogl A, Bauer L, Hodirnau V Nat Struct Mol Biol. 2024; 31(7):1114-1123.

PMID: 38316877 PMC: 11257981. DOI: 10.1038/s41594-023-01201-6.


Palisade structure in intact vaccinia virions.

Hernandez-Gonzalez M, Calcraft T, Nans A, Rosenthal P, Way M mBio. 2024; 15(2):e0313423.

PMID: 38171004 PMC: 10865856. DOI: 10.1128/mbio.03134-23.


References
1.
Laliberte J, Weisberg A, Moss B . The membrane fusion step of vaccinia virus entry is cooperatively mediated by multiple viral proteins and host cell components. PLoS Pathog. 2011; 7(12):e1002446. PMC: 3240603. DOI: 10.1371/journal.ppat.1002446. View

2.
Schmidt F, Bleck C, Helenius A, Mercer J . Vaccinia extracellular virions enter cells by macropinocytosis and acid-activated membrane rupture. EMBO J. 2011; 30(17):3647-61. PMC: 3181475. DOI: 10.1038/emboj.2011.245. View

3.
Giotis E, Laidlaw S, Bidgood S, Albrecht D, Burden J, Robey R . Modulation of Early Host Innate Immune Response by an Avipox Vaccine Virus' Lateral Body Protein. Biomedicines. 2020; 8(12). PMC: 7766033. DOI: 10.3390/biomedicines8120634. View

4.
Rajagopal I, Ahn B, Moss B, Mathews C . Roles of vaccinia virus ribonucleotide reductase and glutaredoxin in DNA precursor biosynthesis. J Biol Chem. 1995; 270(46):27415-8. DOI: 10.1074/jbc.270.46.27415. View

5.
Gray R, Beerli C, Pereira P, Scherer K, Samolej J, Bleck C . VirusMapper: open-source nanoscale mapping of viral architecture through super-resolution microscopy. Sci Rep. 2016; 6:29132. PMC: 4931586. DOI: 10.1038/srep29132. View